It’s not exponential: An economist’s view of the epidemiological curve

Summary:
The spread of COVID-19 is not going to follow an exponential curve – and grave errors will follow if analysts believe it will. The number of new cases rises rapidly, peaks, and then declines. It’s called the epidemiological curve. It’s not a theory or hypothesis; it plays out that way every flu season. It is how it has played out in China and Korea for COVID-19. Flattening the peak to avoid overloading the healthcare system is the main medical goal of the seemingly extreme containment policies we have seen to date.
Have you seen the zombie movie “World War Z” with Brad Pitt? One zombie makes two, who make four, who – well, this quickly gets out of hand. In a flash, a supermarket full of humans becomes a raging mass of slavering zombies in Hollywood’s finest

Related Articles

The spread of COVID-19 is not going to follow an exponential curve – and grave errors will follow if analysts believe it will. The number of new cases rises rapidly, peaks, and then declines. It’s called the epidemiological curve. It’s not a theory or hypothesis; it plays out that way every flu season. It is how it has played out in China and Korea for COVID-19. Flattening the peak to avoid overloading the healthcare system is the main medical goal of the seemingly extreme containment policies we have seen to date.

Have you seen the zombie movie “World War Z” with Brad Pitt? One zombie makes two, who make four, who – well, this quickly gets out of hand. In a flash, a supermarket full of humans becomes a raging mass of slavering zombies in Hollywood’s finest make-up.

This is not an exponential growth process.

Why? While zombies never die and they never get better, they do eventually have trouble finding new victims. What’s more, surviving non-zombies start taking extreme containment measures that reduce the rate of infection – and produce great drama. COVID-19 is not the zombie disease – no surprise there – but it may help us think about the virus’s epidemiological features.

With COVID-19, most patients get better (over 70,000 have recovered from the disease),1 some do, tragically, die, and uninfected people start taking measures to reduce the rate of infection.

That is why the number of new cases is not exponential. It rises rapidly, peaks, and then declines. It’s called the epidemiological curve (‘epi curve’ for short).

It is well known to epidemiologists. It’s not a theory, or conjecture. It plays itself out every flu season (Figure 1). The Centers for Disease Control and Prevention (CDC) even has names for the stages, as shown in the bottom panel of Figure 1: investigation, recognition, initiation, acceleration, deceleration, etc.

China’s epi curve for COVID-19

Figure 2 shows the curve for China’s experience with COVID-19 from 31 December 2019 to 11 March 2020. It illustrates why it is easy to first underestimate a disease’s spread by thinking the curve is linear, but then overestimate it by thinking it is exponential. The top-left panel shows the early days, when it didn’t really look like a problem. The bottom-left panel is during the exponential phase, the top-right panel is when its past the peak, and the bottom-right panel is the full timeline as of 11 March 2020. The spike is due to a temporary change in data-gathering standards.2

Plainly, an analyst who was innocent of the shape of the typical epidemiological curve would have gravely underestimated the problem in mid-January 2020. S/he would then have gravely overestimated it in early February.

What is not shown, since it has not happened, is how viruses often come back after they subside. In other words, the epi curve starts to look like a sine wave. Figure 3 shows the results of a recent simulation by epidemiologists on COVID-19’s possible evolution for the rest of 2020.

Figure 3 Simulation of COVID-19’s new case evolution in 2020

Source: Anderson et al. (2020)

As we know, the Chinese government understood both the epi curve and the gravity of the situation. They quickly took extreme measures to reduce the rate of transmission – or they seemed extreme to many at the time.

South Korea has also worked its way into the deceleration phase that Figure 4 shows. The US epi curve as of 11 March 2020 is plotted on the right-scale for comparison; note the differences in the scales.

The red epi curve illustrates what a pandemic like COVID-19 might look like. In COVID-19 cases, about 5% or 10% of those afflicted need hospitalisation. If the epi curve rises too sharply, the number of patients needing intensive care unit (ICU) beds may exceed the capacity of local hospitals.

The point is simple. During its rapid growth phase, the number of people needing hospitalisation can grow in leaps in bounds – so fast that it overwhelms a nation’s healthcare system. This is happening right now in Italy.

This week, the leading Italian newspaper, Corriere della Sera, reported “scenes of wartime triage, where old patients have to be left by the wayside.”

A doctor interviewed by Corriere della Sera said the principle of ‘first come, first served’ has been abandoned. Another doctor said: “The choice is made inside of an emergency room used for mass events, where only COVID-19 patients enter. If a person is between 80 and 95 and has severe respiratory failure, he probably won’t make it.”

That is why Italy is now taking what may seem like extreme measures to many. Only they are not extreme compared to the nightmare alternative of overwhelmed hospitals unable to provide the care people need to survive the disease.

The blue curve in Figure 4 illustrates the epi curve when anti-transmission policies are instituted for public health reasons. The classic ones are shutting offices, factories, schools and government offices, and cancelling large public events. They can get more extreme, as they have in Italy and China, where massive lockdowns, store closures, and transportation bans were or are being used.

Curve-flattening policies, however, have immediate economic consequences. That is the subject of my next column.

Richard E. Baldwin is a professor of international economics at the Graduate Institute of International and Development Studies in Geneva.[1][2][3] He is also President of the Centre for Economic Policy Research (CEPR) since 2016 and Editor-in-Chief of VoxEU, which he founded in June 2007.[4][5] He is a research associate at the National Bureau of Economic Research, where he has been researching globalization and trade for the past 30 years.[6] He was twice elected as a Member of the Council of the European Economic Association.